Change in Management

30th September, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) – Appointment of Senior Management Personnel Dear Sir / Madam, In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee, has today, i.e. 30th September, 2026, approved the appointment of Mr. Viral Gandhi as Chief Technology Officer and as a Senior Management Personnel of the Company with effect from 1st October, 2026. A brief profile of Mr. Viral Gandhi is enclosed as Annexure A. Mr. Gandhi is not related to any Director of the Company. The above information is also available on the website of the Company at www.piramalpharma.com. You are requested to kindly take the above information on record. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Encl.: a/a Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla, Mumbai - 400070 T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com www.piramalpharma.com Annexure A Brief Profile of Mr. Viral Gandhi Mr. Viral Gandhi is President and Group Chief Information Officer, Piramal Group. As a Digital and Change leader, he is responsible for driving tech innovation and reinvention across the Group entities. He enables the businesses to gain competitive advantage by leveraging technology and digital-led platforms to boost engagement with all stakeholders, across touch points. Mr. Gandhi is a Technology & Digital Strategist with deep expertise in building and implementing innovative technology solutions and establish strong technology culture to transform organisations and propel business growth. Prior to joining Piramal Group, Mr. Gandhi served as Chief Information Officer at the Cox & Kings Group and was instrumental in driving business transformation through consumer tech solutions across the group companies, globally. Previously, during his tenure at Tata Consultancy Services (TCS), he partnered with several Fortune 100 clients such as General Electric, NASDAQ, World Bank, HP and Procter & Gamble, in their technology transformation journeys. With over two and half decades of rich experience, Mr. Gandhi has been conferred with several prestigious awards for his contributions in the field of technology and innovation. Mr. Gandhi has completed an Executive Leadership Program from Harvard Business School, USA and a Strategy and Innovation Program from Massachusetts Institute of Technology, USA. He holds a Bachelor’s Degree in Engineering from VJTI, Mumbai, India. Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla, Mumbai - 400070 T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com www.piramalpharma.com